CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling health care giant. The company said Monday that it expanded its board to 16 members following “productive discussions” with shareholder Glenview Capital Management. The data firm FactSet says Glenview holds about a 1% stake in the company. CVS Health Executive Chairman Roger Farah said in a statement that the new board members “will add new thinking and deep market and industry experiences as we focus on driving greater financial and operational performance.”
(Copyright 2024 The Associated Press. All rights reserved.)
